This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Nov;65(5):1065-1066.

doi: 10.1016/j.jhep.2016.07.019. Epub 2016 Jul 25.

Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease"

Aude Desnoyer¹, Minh Patrick Lê², Yazdan Yazdanpanah³, Gilles Peytavin²; co-authors

Affiliations

Affiliations

¹ Pharmacy Department, Geneva University Hospitals, HUG, Geneva, Switzerland. Electronic address: audedesnoyer@gmail.com.
² Pharmaco-Toxicology Department, Bichat-Claude Bernard Hospital, APHP, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, IAME, INSERM UMR 1137, Paris, France.
³ Infectious Diseases & Tropical Department, Bichat-Claude Bernard Hospital, APHP, Paris, France.

PMID: 27460834
DOI: 10.1016/j.jhep.2016.07.019

Comment

Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease"

Aude Desnoyer et al. J Hepatol. 2016 Nov.

. 2016 Nov;65(5):1065-1066.

doi: 10.1016/j.jhep.2016.07.019. Epub 2016 Jul 25.

Authors

Aude Desnoyer¹, Minh Patrick Lê², Yazdan Yazdanpanah³, Gilles Peytavin²; co-authors

Affiliations

¹ Pharmacy Department, Geneva University Hospitals, HUG, Geneva, Switzerland. Electronic address: audedesnoyer@gmail.com.
² Pharmaco-Toxicology Department, Bichat-Claude Bernard Hospital, APHP, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, IAME, INSERM UMR 1137, Paris, France.
³ Infectious Diseases & Tropical Department, Bichat-Claude Bernard Hospital, APHP, Paris, France.

PMID: 27460834
DOI: 10.1016/j.jhep.2016.07.019

No abstract available

PubMed Disclaimer

Comment on

Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G. Desnoyer A, et al. J Hepatol. 2016 Jul;65(1):40-47. doi: 10.1016/j.jhep.2016.02.044. Epub 2016 Mar 4. J Hepatol. 2016. PMID: 26952005
Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease.
Vionnet J, Saouli AC, Pascual M, Stucker F, Decosterd LA, Moradpour D, Chtioui H. Vionnet J, et al. J Hepatol. 2016 Nov;65(5):1063-1065. doi: 10.1016/j.jhep.2016.06.032. Epub 2016 Jul 25. J Hepatol. 2016. PMID: 27469899 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations